Clinical Trial: Plasmapheresis for Nephrogenic Fibrosing Dermopathy (NFD)/Nephrogenic Systemic Fibrosis (NSF)
Study Status: Terminated
Recruit Status: Terminated
Study Type: Interventional
Official Title: Use of Plasmapheresis for Nephrogenic Fibrosing Dermopathy (NFD)/Nephrogenic Systemic Fibrosis (NSF) and Understanding Its Etiology
Brief Summary: The purpose of this study is to evaluate the pathophysiology of nephrogenic fibrosing dermopathy (NFD)/nephrogenic systemic fibrosis (NSF).
Detailed Summary:
Sponsor: Loma Linda University
Current Primary Outcome: Improve elasticity of skin, including increased range of motion of compromised joints due to leathery skin [ Time Frame: Assessed two weeks after each monthly course of plasmapheresis ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Loma Linda University
Dates:
Date Received: February 5, 2010
Date Started: February 2002
Date Completion:
Last Updated: November 19, 2014
Last Verified: November 2014